














This work is licensed under a Creative Commons Attribution 3.0 Unported License 
 
 
Newcastle University ePrints - eprint.ncl.ac.uk 
 
Anjum SA, Lawrence H, Holland JP, Kirby JA, Deehan DJ, Tyson-Capper AJ. 
Effect of cobalt-mediated Toll-like receptor 4 activation on inflammatory 
responses in endothelial cells. Oncotarget 2016 
Copyright: 
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 
License.  
DOI link to article: 
http://dx.doi.org/10.18632/oncotarget.13260 




www.impactjournals.com/oncotarget/ Oncotarget, Vol. 7, No. 47
Effect of cobalt-mediated Toll-like receptor 4 activation on 
inflammatory responses in endothelial cells
Sami A. Anjum1,*, Helen Lawrence1,3,*, James P. Holland2,3, John A. Kirby1, David J. 
Deehan2,3 and Alison J. Tyson-Capper1
1 Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK
2 Department of Orthopaedics, Freeman Hospital, Newcastle upon Tyne, UK
3 Northern Retrieval Centre, Freeman Hospital, Newcastle upon Tyne, UK
* Joint first authors
Correspondence to: Alison J. Tyson-Capper, email: alison.tyson-capper@ncl.ac.uk
Keywords: cobalt, TLR4, endothelium, inflammation, metal-on-metal, Immunology and Microbiology Section, Immune response, 
Immunity
Received: July 15, 2016 Accepted: November 02, 2016 Published: November 09, 2016
ABSTRACT
Cobalt-containing metal-on-metal hip replacements are associated with adverse 
reactions to metal debris (ARMD), including inflammatory pseudotumours, osteolysis, 
and aseptic implant loosening. The exact cellular and molecular mechanisms leading 
to these responses are unknown. Cobalt ions (Co2+) activate human Toll-like receptor 
4 (TLR4), an innate immune receptor responsible for inflammatory responses to Gram 
negative bacterial lipopolysaccharide (LPS). 
We investigated the effect of Co2+-mediated TLR4 activation on human 
microvascular endothelial cells (HMEC-1), focusing on the secretion of key 
inflammatory cytokines and expression of adhesion molecules. We also studied 
the role of TLR4 in Co2+-mediated adhesion molecule expression in MonoMac 6 
macrophages. 
We show that Co2+ increases secretion of inflammatory cytokines, including 
IL-6 and IL-8, in HMEC-1. The effects are TLR4-dependent as they can be prevented 
with a small molecule TLR4 antagonist. Increased TLR4-dependent expression of 
intercellular adhesion molecule 1 (ICAM1) was also observed in endothelial cells and 
macrophages. Furthermore, we demonstrate for the first time that Co2+ activation 
of TLR4 upregulates secretion of a soluble adhesion molecule, sICAM-1, in both 
endothelial cells and macrophages. Although sICAM-1 can be generated through 
activity of matrix metalloproteinase-9 (MMP-9), we did not find any changes in MMP9 
expression following Co2+ stimulation. 
In summary we show that Co2+ can induce endothelial inflammation via activation 
of TLR4. We also identify a role for TLR4 in Co2+-mediated changes in adhesion 
molecule expression. Finally, sICAM-1 is a novel target for further investigation in 
ARMD studies.
INTRODUCTION
Metal-on-metal (MoM) hip replacements are 
associated with the development of adverse reactions 
to metal debris (ARMD), which includes inflammatory 
pseudotumours, soft tissue necrosis, osteolysis and 
resulting aseptic implant loosening. Peri-implant tissues 
are often infiltrated by monocytes, macrophages and 
lymphocytes (referred to as aseptic lymphocyte-dominated 
vasculitis-associated lesion, ALVAL) which is indicative 
of an inflammatory response. However the cellular and 
molecular mechanisms that underlie ARMD are not well-
understood. 
Co2+ from MoM implants activates human Toll-
like receptor 4 (TLR4) [1-3], an innate immune receptor 
expressed on immune cells as well as endothelial 
and epithelial cells. The major ligand for TLR4 is 
lipopolysaccharide from Gram negative bacteria, and 
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receptor activation causes adaptor protein recruitment and 
an intracellular signalling cascade that upregulates the 
activity of transcription factors including NFκB [3]. 
We have previously shown that activation of TLR4 
by Co2+ increases the secretion of inflammatory cytokines, 
including interleukin-8 (IL-8) and chemokine (C-X-C 
motif) ligand 10 (CXCL10), in MonoMac 6 macrophages 
[4]. Previous studies investigating the inflammatory 
effects of Co2+ in endothelial cells have primarily focused 
on endothelial cells transfected with TLR4 and its co-
receptor MD2 [3, 5], but few studies have investigated the 
effect of Co2+ on endogenous TLR4-expressing endothelial 
cell lines. Endothelial cells are exposed to Co2+ present 
in the blood of MoM hip replacement patients [6] and 
therefore understanding the cellular response is important 
in defining the causes of ARMD and identifying potential 
therapeutic targets for ARMD prevention. 
In the present study we assessed the immune 
response of endothelial cells to Co2+, with a focus on the 
role of TLR4. We also investigated the effect of Co2+ on 
adhesion molecule expression by endothelial cells and 
macrophages because of their critical role in inflammatory 
process such as leukocyte binding and extravasation. 
RESULTS
Co2+ activation of TLR4 increases IL-8 and IL-6 
secretion
HMEC-1 cells were stimulated with 0.25-1mM 
cobalt chloride hexahydrate (Co2+) or 100ng/ml LPS 
for 24h and supernatant was collected for ELISA. IL-8 
secretion was significantly increased by all concentrations 
of Co2+ (all p < 0.001 except 0.25mM where p = 0.026), 
peaking at 1300pg/ml with 1mM Co2+. The positive 
control LPS also increased IL-8 secretion (Figure 1A). 
IL-6 secretion was similarly upregulated by the agonists 
(all p < 0.001 except 0.25mM where p = 0.011) (Figure 
1B). 
To assess the role of TLR4 in the observed cytokine 
secretion, HMEC-1 were pre-incubated with 1μg/ml 
CLI-095 (a small molecule TLR4 antagonist) for 6h 
followed by stimulation with 0.75mM Co2+ or 100ng/
ml LPS for 24h. IL-8 and IL-6 secretion were measured 
by ELISA. Pre-treatment with CLI-095 significantly 
Figure 1: Effect of Co2+ ions and TLR4 activation on cytokine secretion by HMEC-1. A. & B. HMEC-1 were stimulated with 
0.25-1mM Co2+ or 100ng/ml LPS. A. IL-8 and B. IL-6 secretion were assessed by ELISA. C. & D. HMEC-1 were pre-treated with 1μg/
ml CLI-095 followed by 24h stimulation with 0.75mM Co2+ or 100ng/ml LPS. C. IL-8 and D. IL-6 secretion was quantified by ELISA. All 
data is representative of three independent experiments. 
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decreased secretion of both cytokines in response to 
Co2+ (p < 0.001), showing that their release is TLR4-
dependent. The cytokine release was not a result of Co2+-
mediated cytotoxicity as trypan blue staining revealed no 
change in HMEC-1 viability following cobalt stimulation 
(Supplementary Material, Figure 6). 
Co2+-mediated TLR4 activation increases ICAM1 
expression in endothelial cells and macrophages
Endothelial cells are known to express adhesion 
molecules, including intercellular adhesion molecule-1 
Figure 3: Effect of Co2+ and TLR4 activation on sICAM-1 secretion. A. HMEC-1 or B. MonoMac 6 cells were stimulated with 
0.25-1mM Co2+ for 24h and sICAM-1 secretion was measured by ELISA. C. HMEC-1 or D. MonoMac 6 cells were pre-incubated with 
1μg/ml CLI-095 for 6h before stimulation with 0.75mM Co2+ or 100ng/ml LPS. All data is representative of three independent experiments. 
Figure 2: Effect of Co2+ and TLR4 activation on ICAM1 expression. A. HMEC-1 and B. MonoMac 6 cells were stimulated with 
1μg/ml CLI-095 for 6h prior to 24h stimulation with 0.75mM Co2+ or 100ng/ml LPS. RNA was isolated and cDNA synthesised by reverse 
transcription. ICAM1 expression was quantified by qRT-PCR. Data is representative of three independent experiments.
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(ICAM-1) and vascular adhesion molecule-1 (VCAM-
1), which are essential in leukocyte extravasation in 
inflammation. We assessed the effect of Co2+ activation of 
TLR4 on ICAM1 expression in HMEC-1 and MonoMac 6 
macrophages. Macrophages also express CAMs for cell-
cell communication. 
Co2+ induced a small but significant 3-fold 
upregulation in ICAM1 expression by HMEC-1 (p = 
0.013) (Figure 2A) and a larger 35-fold upregulation in 
MonoMac 6 cells (p < 0.001) (Figure 2B). In both cell 
lines the response was found to be TLR4-dependent 
because it was inhibited by the TLR4 antagonist CLI-095 
(both p < 0.001). 
Co2+ increases secretion of sICAM-1 in a TLR4-
dependent manner
In addition to its membrane-bound form, ICAM-
1 can also be secreted as soluble ICAM-1 (sICAM-1). 
Given the TLR4-dependent increase in ICAM1 expression 
described in Figure 2, we hypothesised that sICAM-1 
release would also be affected by Co2+. Secretion of 
sICAM-1 by stimulated HMEC-1 and MonoMac 6 cells 
was investigated by ELISA. Cells were stimulated with 
0.25-1mM Co2+ or 100ng/ml LPS for 24h. In HMEC-1, 
sICAM-1 secretion was increased by Co2+ concentrations 
of 0.5mM and above (all p < 0.001), peaking at 900pg/ml 
with 1mM Co2+ stimulation (Figure 3A). LPS increased 
sICAM-1 release to more than 1000pg/ml (p < 0.001). In 
MonoMac 6 cells sICAM-1 release was elevated across all 
Co2+ concentrations, peaking at 1000pg/ml with 0.5mM 
treatment (p < 0.001) (Figure 3B). As in HMEC-1, LPS 
elicited more sICAM-1 release than Co2+.
HMEC-1 and MonoMac 6 cells were then pre-
incubated with 1μg/ml CLI-095 for 6h followed by 
24h stimulation with either 0.75mM Co2+ or 100ng/ml 
LPS. There was a significant decrease in Co2+ and LPS-
mediated sICAM-1 secretion in both HMEC-1 (Figure 3C) 
and MonoMac 6 cells (Figure 3D) (p < 0.001 in all cases). 
This shows that sICAM-1 release in response to Co2+ and 
LPS is TLR4-dependent. 
Co2+-mediated sICAM-1 secretion is not a result 
of MMP-9 activity
Previous studies have shown that sICAM-1 can be 
produced when mICAM-1 is cleaved by the gelatinase 
matrix metalloprotease-9 (MMP-9) [7]. LPS stimulates 
MMP-9 activity through activation of TLR4. We therefore 
investigated whether or not Co2+ activation of TLR4 also 
increases MMP-9 expression. HMEC-1 and MonoMac6 
cells were pre-treated with 1μg/ml CLI-095 for 6h 
followed by 24h stimulation with 0.75mM Co2+ or 100ng/
ml LPS. MMP9 expression was assessed using qRT-PCR. 
HMEC-1 exhibited a significant 16-fold increase 
in MMP9 expression following stimulation with 100ng/
ml LPS (p < 0.001) (Figure 4A). This was inhibited by 
CLI-095, showing that it is a TLR4-dependent effect 
(p < 0.001). In contrast there was no change in MMP9 
expression in response to Co2+ (p = 0.999) (Figure 4A). 
A similar pattern was observed in MonoMac 6 cells; 
following LPS stimulation there was a 7-fold increase 
in MMP9 expression by (p < 0.001) (Figure 4B). CLI-
095 inhibited this upregulated expression, showing that 
it is TLR4-dependent. However there was no increase in 
MMP9 expression in response to Co2+, although CLI-095 
decreased its expression further.
DISCUSSION
In the present study we describe a TLR4-dependent 
inflammatory response to Co2+ in human endothelial cells 
Figure 4: Effect of Co2+ and LPS on MMP9 expression. A. HMEC-1 or B. MonoMac6 cells were pre-treated with 1μg/ml CLI-
095 for 6h prior to stimulation with 0.75mM Co2+ or 100ng/ml LPS for 24h. MMP9 expression was assessed by qRT-PCR. All data is 
representative of at least two independent experiments. 
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and macrophages. HMEC-1 exhibited significant increases 
in secretion of inflammatory cytokines IL-8 and IL-6 when 
stimulated with Co2+. This was inhibited by the TLR4 
antagonist CLI-095, showing that the receptor is central 
to the responses. Previous studies have shown that Co2+ 
upregulates adhesion molecule expression [8-10], but have 
not demonstrated the exact signalling pathways involved. 
The data obtained in this study supports the findings of 
these studies and also indicates a previously unidentified 
role for TLR4 in Co2+-mediated ICAM1 expression in 
both endothelial cells and macrophages. Furthermore, 
for the first time a soluble adhesion molecule, sICAM-1, 
was detected in conditioned media from Co2+ and LPS-
stimulated HMEC-1 and MonoMac 6 cells. CLI-095 
inhibited sICAM-1 changes and consequently they are 
TLR4-dependent. 
We investigated the effect of Co2+ on MMP9 
expression because MMP-9 can cleave membrane-
bound ICAM-1 resulting in the release of its soluble 
form, sICAM-1. In addition, MMP-9 can be regulated by 
LPS activation of TLR4 [11] and therefore it is possible 
that Co2+-mediated TLR4 activation results in MMP-9 
activity and sICAM-1 generation. However, although 
LPS increased MMP9 expression in a TLR4-dependent 
manner, there was no change in expression in response to 
Co2+. The absence of any effect was consistent between 
HMEC-1 and MonoMac 6 cells. The lack of change in 
MMP9 expression following Co2+ stimulation suggests 
that the enzyme is not responsible for the changes in 
sICAM-1 secretion observed in response to Co2+. Other 
proteolytic enzymes potentially involved in sICAM-1 
cleavage include serine proteases [12], neutrophil elastase 
[13], and cathepsin G [14]. However the effect of Co2+ on 
these factors remains to be elucidated. 
sICAM-1 has previously been proposed as a 
marker of inflammation [15] that is cleaved to regulate 
inflammatory responses but studies are now reporting 
a broader role for sICAM-1, including promotion of 
angiogenesis and neovascularisation [16]. This is of 
particular interest to the present study because blood vessel 
Figure 5: Working model. A. Co2+ released from metal-on-metal (MoM) hip implants activates TLR4 on immune cells such as 
macrophages. B. Co2+-mediated TLR4 activation results in the release of inflammatory cytokines and chemokines, including IL-8, by 
macrophages and endothelial cells. The generated cytokine/chemokine gradient attracts circulating leukocytes, such as monocytes and 
neutrophils. C. Co2+ activation of TLR4 on endothelial cells increases expression of ICAM-1, which promotes leukocyte binding via 
interaction with LFA-1. This in turn drives leukocyte extravasation. D. Migrated leukocytes, together with sICAM-1 released by endothelial 
cells and macrophages, promote an inflammatory response that may contribute to inflammation and pseudotumour development around a 
MoM implant.
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formation is required for pseudotumour development, 
which is a major factor in ARMD. Soft tissue necrosis 
is also a common feature of ARMD and can result from 
vascular inflammation restricting oxygen supply to the 
tissues. The ability of Co2+ to cause an inflammatory 
response, including pro-inflammatory cytokine release, in 
endothelial cells may indicate that similar effects occur 
in vitro, which could result in ischaemia and subsequent 
tissue death.
A limitation of the present study is the high Co2+ 
concentrations that we have used to stimulate the cells. 
Even the concentrations at the lower end of the range are 
considerably higher than those detected in the serum and 
synovial fluid of patients with failed MoM implants [17-
19]. However, the Co2+ concentrations used in our study 
are in line with those of similar in vitro studies of the 
inflammatory effects of metal ions [3, 10, 20, 21]. Hence, 
they are appropriate and relevant for this study. 
A working model of the possible mechanisms 
indicated by our results is shown in Figure 5. In summary, 
we have shown that Co2+ has the potential to induce 
an inflammatory response in the endothelium through 
activation of TLR4. It also shows for the first time that 
Co2+ increases sICAM-1 secretion in a TLR4-dependent 
manner. Although the exact mechanism of its release 
remains unclear, sICAM-1 is an interesting target for 
further investigation in ARMD because of its previously 
described roles in angiogenesis, neovascularisation and 
tumour formation [16]. 
MATERIALS AND METHODS
Cell culture
Human microvascular endothelial cells (HMEC-1) 
are derived from dermal foreskin. Cells were cultured in 
MCDB131 (Sigma-Aldrich, Gillingham, UK) medium 
supplemented with 10% foetal bovine serum (FBS), 50U/
ml penicillin, 50μg/ml streptomycin, 10ng/ml epidermal 
growth factor (EGF) and 1μg/ml hydrocortisone (all 
Sigma-Aldrich). 
MonoMac 6 cells are a human TLR4-expressing cell 
line derived from acute monocytic leukaemia. Cells were 
cultured as previously described [22].
Cell stimulation
Cells were stimulated with cobalt chloride 
hexahydrate (referred to as Co2+ in this study) in complete 
culture medium appropriate for each cell line. Complete 
culture medium was used as a negative control while 
100ng/ml TLR4-specific LPS (Alexis Biochemicals, San 
Diego, USA) provided a positive control. 
ELISA (IL-8, IL-6, sICAM-1)
Inflammatory cytokine secretion was quantified by 
enzyme-linked immunosorbent assay (ELISA). IL-6, IL-8 
and sICAM-1 ELISA kits were purchased from Peprotech 
(London, UK) and assays performed as described 
previously [4]. 
qRT-PCR
Gene expression changes were assessed by 
quantitative reverse transcriptase polymerase chain 
reaction (qRT-PCR) using TaqMan primers and probes 
(ThermoFisher Scientific, Massachusetts, USA). RNA was 
isolated using a Qiagen RNeasy Mini kit (Qiagen, Venlo, 
Netherlands) and cDNA synthesised using Superscript III 
reverse transcriptase (ThermoFisher Scientific). Each qRT-
PCR reaction contained 5μl TaqMan Gene Expression 
Mastermix (ThermoFisher Scientific), 2μl diluted cDNA 
template, 2.5μl nuclease-free H2O and 0.5μl TaqMan 
Gene Expression Assay (ThermoFisher Scientific). No 
template controls with nuclease-free H2O instead of cDNA 
were included. All reactions were performed in triplicate 
and target gene expression was normalised to GAPDH 
expression. 
CLI-095
Inhibition of TLR4 was performed by pre-incubating 
cells for 6h with 1μg/ml CLI-095. CLI-095 (Invivogen, 
UK) is a small molecule TLR4 antagonist that binds to 
the intracellular domain of the receptor and prevents 
recruitment of downstream adaptor proteins. 
Cytotoxicity assay
Cytotoxicity was assessed by trypan blue staining. 
Stimulated cells were resuspended in a small volume of 
supernatant and 10μl cell suspension was mixed with 
10μl trypan blue dye. Staining was visualised on a Luna 
II automated cell counter (Logos Biosystems, Virginia, 
USA)
Statistical analysis
Statistical significance was calculated using a one-
way analysis of variance (ANOVA). When samples were 
compared to an untreated control (Figures 1A, 1B, 3A, 
and 3B), Dunnett’s test for multiple comparisons was 
performed. When comparing all samples to each other, 
Tukey’s test for multiple comparisons was performed. 
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